SanBio Company Limited
SNBIF
$16.45
$2.1715.20%
OTC PK
| 07/31/2024 | 04/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -7.63% | -34.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.67% | -20.70% | |||
| Operating Income | -30.67% | 20.70% | |||
| Income Before Tax | -1,435.81% | 111.15% | |||
| Income Tax Expenses | -146.04% | 686.52% | |||
| Earnings from Continuing Operations | -677.95% | 81.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -677.95% | 81.66% | |||
| EBIT | -30.67% | 20.70% | |||
| EBITDA | -31.06% | 20.77% | |||
| EPS Basic | -677.70% | 82.23% | |||
| Normalized Basic EPS | -1,423.21% | 108.83% | |||
| EPS Diluted | -677.70% | 82.23% | |||
| Normalized Diluted EPS | -1,423.21% | 108.83% | |||
| Average Basic Shares Outstanding | 0.28% | 3.01% | |||
| Average Diluted Shares Outstanding | 0.28% | 3.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||